Yale University: Drug-Induced Pneumonitis - Risk Behind Cancer Therapies
January 22, 2026
January 22, 2026
NEW HAVEN, Connecticut, Jan. 22 (TNSjou) -- Yale University issued the following news:
* * *
Drug-Induced Pneumonitis: The Risk Behind New Cancer Therapies
By Avi Patel
Advances in lung cancer treatment have changed survival in ways that were unimaginable even a decade ago. Targeted drugs, immunotherapies, and emerging antibody--drug conjugates are helping many patients live longer--and live well. But these gains may come with risks, including . . .
* * *
Drug-Induced Pneumonitis: The Risk Behind New Cancer Therapies
By Avi Patel
Advances in lung cancer treatment have changed survival in ways that were unimaginable even a decade ago. Targeted drugs, immunotherapies, and emerging antibody--drug conjugates are helping many patients live longer--and live well. But these gains may come with risks, including . . .